These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 23696114

  • 1. Serum sodium identifies patients with cirrhosis at high risk of hepatorenal syndrome.
    Janičko M, Veselíny E, Abraldes JG, Jarčuška P.
    Z Gastroenterol; 2013 Jul; 51(7):628-34. PubMed ID: 23696114
    [Abstract] [Full Text] [Related]

  • 2. Predictors of hepatorenal syndrome in alcoholic liver cirrhosis.
    Janicko M, Veseliny E, Senajova G, Jarcuska P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):661-5. PubMed ID: 25820623
    [Abstract] [Full Text] [Related]

  • 3. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P.
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [Abstract] [Full Text] [Related]

  • 4. Serum cystatin C in advanced liver cirrhosis and different stages of the hepatorenal syndrome.
    Barakat M, Khalil M.
    Arab J Gastroenterol; 2011 Sep; 12(3):131-5. PubMed ID: 22055590
    [Abstract] [Full Text] [Related]

  • 5. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
    Sharma P, Kumar A, Shrama BC, Sarin SK.
    Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
    [Abstract] [Full Text] [Related]

  • 6. [Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score].
    Zhang JY, Qin CY, Jia JD, Wang BE.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):108-11. PubMed ID: 22464781
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study.
    Schepke M, Appenrodt B, Heller J, Zielinski J, Sauerbruch T.
    Liver Int; 2006 Sep; 26(7):834-9. PubMed ID: 16911466
    [Abstract] [Full Text] [Related]

  • 8. Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.
    Ghosh S, Choudhary NS, Sharma AK, Singh B, Kumar P, Agarwal R, Sharma N, Bhalla A, Chawla YK, Singh V.
    Liver Int; 2013 Sep; 33(8):1187-93. PubMed ID: 23601499
    [Abstract] [Full Text] [Related]

  • 9. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.
    Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, Rodés J, Ginès P.
    Hepatology; 2005 Jun; 41(6):1282-9. PubMed ID: 15834937
    [Abstract] [Full Text] [Related]

  • 10. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels.
    Ahn HS, Kim YS, Kim SG, Kim HK, Min SK, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS, Park JM.
    Hepatogastroenterology; 2012 Jun; 59(116):1168-73. PubMed ID: 22057374
    [Abstract] [Full Text] [Related]

  • 11. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F, Pantea L, Sniderman K.
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [Abstract] [Full Text] [Related]

  • 12. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
    von Kalckreuth V, Glowa F, Geibler M, Lohse AW, Denzer UW.
    Z Gastroenterol; 2009 Jan; 47(1):21-6. PubMed ID: 19156588
    [Abstract] [Full Text] [Related]

  • 13. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
    Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J.
    Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis.
    Serra MA, Puchades MJ, Rodríguez F, Escudero A, del Olmo JA, Wassel AH, Rodrigo JM.
    Scand J Gastroenterol; 2004 Nov; 39(11):1149-53. PubMed ID: 15545175
    [Abstract] [Full Text] [Related]

  • 15. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
    Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG.
    Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386
    [Abstract] [Full Text] [Related]

  • 16. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
    Park SH, Park HY, Kang JW, Park JS, Shin KJ, Kim CH, Suk KT, Baik GH, Kim JB, Kim DJ, Lee HY.
    Hepatogastroenterology; 2012 Mar; 59(120):2548-51. PubMed ID: 23178621
    [Abstract] [Full Text] [Related]

  • 17. Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome.
    Ibrahim ES, Alsebaey A, Zaghla H, Moawad Abdelmageed S, Gameel K, Abdelsameea E.
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1247-1250. PubMed ID: 28902040
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of the relationship between hepatorenal syndrome and plasma ammonia].
    He Y, Li GX, Xia Y.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):45-8. PubMed ID: 20128969
    [Abstract] [Full Text] [Related]

  • 19. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F, Raina N, Richardson R.
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [Abstract] [Full Text] [Related]

  • 20. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.